The neuroendocrine hormone arginine vasopressin (AVP) and analogs with selective V1A receptor-agonist activity are increasingly used to treat catecholamine-refractory septic shock and the irreversible phase of fluid-resuscitated hemorrhagic shock, another form of distributive shock like septic shock [6]. Here, AVP is linked to septic shock.